Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Unknown 2Recruiting 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Neoplasms 181Carcinoma, Non-Small-Cell Lung 172Breast Neoplasms 172Colorectal Neoplasms 104Stomach Neoplasms 80Pancreatic Neoplasms 78Lung Neoplasms 78Prostatic Neoplasms 75Recurrence 66Neoplasm Metastasis 66Melanoma 66Leukemia, Myeloid, Acute 66Multiple Myeloma 65Ovarian Neoplasms 61Carcinoma, Hepatocellular 61Lymphoma 60Advanced Solid Tumor 60Advanced Solid Tumors 56Solid Tumor 50Uterine Cervical Neoplasms 47Lymphoma, Non-Hodgkin 47Glioblastoma 44Lymphoma, B-Cell 39Leukemia 39Colonic Neoplasms 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Head and Neck Neoplasms 33Sarcoma 30Esophageal Neoplasms 30Urinary Bladder Neoplasms 29

Interventions

Sensitivity and Specificity 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × INDUSTRY × Enteropathy-Associated T-Cell Lymphoma × Clear all
NCT04480788 2021-01-06

CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Phase 1 Unknown
9 enrolled
Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Enteropathy-Associated T-Cell Lymphoma

NCT02742727 2016-12-06

CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Phase 1/2 Unknown
10 enrolled
LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Leukemia, Prolymphocytic, T-Cell, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Leukemia, Large Granular Lymphocytic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Enteropathy-Associated T-Cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡